Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Circulation

• Publication date

  1987-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.76.6.1312PMID 2890447
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of acetaminophen on the disposition of fenoldopam: Competition for sulfation

  1987cited by this paper
• The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro.

  1986cited by this paper
• Dopamine inhibits the aldosterone response to upright posture.

  1986cited by this paper
• The kidney and effective antihypertensive therapy.

  1985cited by this paper
• Hypokalemia from beta2-receptor stimulation by circulating epinephrine.

  1985cited by this paper
• Blockade of renal effects of dopamine in the dog by the DA1 antagonist SCH 23390.

  1985cited by this paper
• Hemodynamic effects of an oral dopamine receptor agonist (fenoldopam) in patients with congestive heart failure.

  1985cited by this paper
• Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension.

  1984cited by this paper
• Dopamine receptors in the proximal tubule of the rabbit.

  1984cited by this paper
• Beneficial hemodynamic effects of oral levodopa in heart failure. Relation to the generation of dopamine.

  1984cited by this paper
• Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension.

  1984cited by this paper
• Hypokalemia from beta 2-receptor stimulation by circulating epinephrine.

  1983cited by this paper
• Synergism of dopamine and furosemide in diuretic-resistant, oliguric acute renal failure.

  1983cited by this paper
• A new oral renal vasodilator, fenoldopam

  1983cited by this paper
• Studies on the mechanism of sodium excretion during drug-induced vasodilatation in the dog.

  1982cited by this paper
• Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.

  1982cited by this paper
• Dopamine decreases fluid reabsorption in straight portions of rabbit proximal tubule.

  1982cited by this paper
• Dopamine administration in oliguria and oliguric renal failure

  1981cited by this paper
• Minoxidil: A Review of its Pharmacological Properties and Therapeutic Use

  1981cited by this paper
• Dopaminergic modulation of aldosterone secretion in man is unaffected by glucocorticoids and angiotensin blockade.

  1981cited by this paper
• The Pharmacology of Verapamil. III. Pharmacokinetics in Normal Subjects After Intravenous Drug Administration

  1981cited by this paper
• Dopamine hydrochloride in oliguric states.

  1980cited by this paper
• [Relations between the natriuretic effects of dopamine and sodium metabolism].

  1978cited by this paper
• Effects of dopaminergic agonists and antagonists on isolated cerebral blood vessels.

  1978cited by this paper
• Letter: Simplified determination of plasma inulin in testing kidney function.

  1976cited by this paper
• Effects of dopamine on isolated canine coronary arteries.

  1975cited by this paper
• Radioimmunoassay of plasma aldosterone.

  1974cited by this paper
• Hypertension with renal impairment: influence of intensive therapy.

  1974cited by this paper
• Quantitative importance of changes in postglomerular colloid osmotic pressure in mediating glomerulotubular balance in the rat.

  1973cited by this paper
• Cardiovascular and renal actions of dopamine: potential clinical applications.

  1972cited by this paper
• PERIPHERAL VASCULAR AND OTHER EFFECTS OF DOPAMINE INFUSIONS IN MAN.

  1964cited by this paper
• Hydrallazine (apresoline) hydrochloride; pharmacological observations and clinical results in the therapy of hypertension.

  1953cited by this paper
• A rapid method for the determination of para-aminohippuric acid in kidney function tests.

  1951cited by this paper

• A Metabolic Framework for Reward: Redefining Dopamine and Opioids as Physiological Agents.

  2026cites this paper
• Effects of Fenoldopam in the Pediatric Population: Fluid Status, Serum Biomarkers, and Hemodynamics: A Systematic Review and Meta-Analysis

  2020cites this paper
• Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment

  2017cites this paper
• The Renin-Angiotensin and Renal Dopaminergic Systems Interact in Normotensive Humans.

  2016cites this paper
• Administration of fenoldopam in critically ill small animal patients with acute kidney injury: 28 dogs and 34 cats (2008-2012).

  2015cites this paper
• Vasoactive Drugs in Acute Care

  2014cites this paper
• Contrast‐induced nephropathy: Protective role of fenoldopam

  2012cites this paper
• Fenoldopam use in a burn intensive care unit: a retrospective study

  2010influential citation
• Safety and Performance of Targeted Renal Therapy: The Be-RITe! Registry

  2009cites this paper
• Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis.

  2008cites this paper
• N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery

  2008cites this paper
• Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group.

  2008cites this paper
• Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials.

  2007cites this paper
• Medications for Improving Urine Output and Renal Insufficiency Following Surgery for Congenital Heart Disease: A Case Study

  2007cites this paper
• Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).

  2006cites this paper
• A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients*

  2006cites this paper
• Debrisoquine oxidation phenotype and susceptibility to lung cancer

  2006cites this paper
• Fenoldopam Improves Corticomedullary Oxygen Delivery and Attenuates Angiogenesis Gene Expression in Acute Ischemic Renal Injury

  2006cites this paper
• Radiocontrast-Induced Acute Renal Failure

  2005cites this paper
• Chapter 77 – Anesthesia and Hypertension

  2005cites this paper
• Prophylactic fenoldopam for renal protection in sepsis: A randomized, double-blind, placebo-controlled pilot trial*

  2005cites this paper
• Cardiovascular and Renal Hemodynamic Effects of Intravenous Infusions of the Selective DA1 Agonist, Fenoldopam, Used Alone or in Combination With Dopamine and Dobutamine

  2005cites this paper
• Renoprotective Action of Fenoldopam in High-Risk Patients Undergoing Cardiac Surgery: A Prospective, Double-Blind, Randomized Clinical Trial

  2005cites this paper
• Interaction study of fenoldopam — digoxin in congestive heart failure

  2004cites this paper
• The Abnormal Renal Vasodilator Response to D1-Like Receptor Stimulation in Conscious SHR Can Be Normalized by AT1 Blockade

  2004cites this paper
• A single dose study of the effects of fenoldopam and enalapril in mild hypertension

  2004cites this paper
• Renal protection strategies in the perioperative period

  2004cites this paper
• Renal protection strategies in the perioperative period.

  2004cites this paper
• Inhibition of the aldosterone response to sodium depletion in man by stimulation of dopamine DA2 receptors

  2004cites this paper
• Complications of Major Aortic and Lower Extremity Vascular Surgery

  2004cites this paper
• Effect of Fenoldopam on Renal Function Following Nephrotomy in Normal Dogs

  2003cites this paper
• Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass.

  2003cites this paper
• Monitoring Renal Oxygen Supply in Critically-Ill Patients Using Urinary Oxygen Tension

  2003cites this paper
• Effect of fenoldopam on renal function after nephrotomy in normal dogs.

  2003cites this paper
• Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.

  2003cites this paper
• New Drugs: Fenoldopam Mesylate, Glycoprotein IIb/IIIa Antagonists, and K + ATP -Channel Agonists

  2002cites this paper
• The effects of fenoldopam on renal function in patients undergoing elective aortic surgery.

  2002cites this paper
• Pharmacological Review of Postoperative Hypertension

  2002cites this paper
• Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy.

  2002cites this paper
• Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension.

  2001cites this paper
• Use of fenoldopam for prevention of radiocontrast nephropathy in the cardiac catheterization laboratory: a case series.

  2001cites this paper
• Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting

  2001cites this paper
• The effects of fenoldopam on coronary conduit blood flow after coronary artery bypass graft surgery.

  2001cites this paper
• New Drugs: Fenoldopam Mesylate, Glycoprotein IIb/IIIa Antagonists, and KATP

  2001cites this paper
• Effects of prophylactic fenoldopam infusion on renal blood flow and renal tubular function during acute hypovolemia in anesthetized dogs

  2001cites this paper
• Fenoldopam Infusion Associated with Preserving Renal Function After Aortic Cross-Clamping for Aneurysm Repair

  2001cites this paper
• Fenoldopam: Novo Antihipertensivo Parenteral; Alternativa ao Nitroprussiato? * Fenoldopan: A New Parenteral Anti-hypertensive; an Alternative to Nitroprusside?

  2001cites this paper
• Renal blood flow changes induced with endothelin-1 and fenoldopam mesylate at quantitative Doppler US: initial results in a canine study.

  2001cites this paper
• Oliguria in the ICU. Systematic approach to diagnosis and treatment.

  2000cites this paper
• New pharmacologic options for renal preservation.

  2000cites this paper
• RENAL DOPAMINERGIC MECHANISMS AND HYPERTENSION: A CHRONOLOGY OF ADVANCES

  2000cites this paper
• The effects of fenoldopam on renal blood flow and tubular function during aortic cross-clamping in anaesthetized dogs.

  2000cites this paper
• Dopamine: a role in the pathogenesis and treatment of hypertension

  2000cites this paper
• Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects.

  1999cites this paper
• Cardiac management in the ICU.

  1999cites this paper
• Impaired renal vascular response to a D1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive rats.

  1999cites this paper
• Sustained Hemodynamic Effects of the Selective Dopamine‐1 Agonist, Fenoldopam, during 48‐Hour Infusions in Hypertensive Patients: A Dose‐Tolerability Study

  1999cites this paper
• The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects.

  1999cites this paper
• The effect of fenoldopam on the blood pressure of the rat.

  1999cites this paper
• Fenoldopam: A New Dopamine Agonist for the Treatment of Hypertensive Urgencies and Emergencies

  1998cites this paper
• Potential of dopamine A-1 agonists in the management of acute renal failure.

  1998cites this paper
• Effects of long-term application of dopamine HCl on dopamine agonist-induced cAMP production in rat renal cortex.

  1998cites this paper
• Perioperative Hypertension

  1998cites this paper
• Perioperative renal preservation: Dopexamine and fenoldopam— New agents to augment renal performance

  1998cites this paper
• DA1‐receptor stimulation by fenoldopam in the treatment of postcardiac surgical hypertension

  1998cites this paper
• Renal dopamine receptor function in hypertension.

  1998cites this paper
• Fenoldopam Review of its Pharmacodynamic and Pharmacokinetic Properties and Intravenous Clinical Potential in the Management of Hypertensive Urgencies and Emergencies

  1997cites this paper
• Cardiovascular Actions of the Dopamine Receptor Agonist Z1046 in Swine

  1997cites this paper
• Circulatory Support, Dopamine, and Dopamine Agonists as Adjuncts to Diuretic Therapy

  1997cites this paper
• Dopamine D1A receptors and renin release in rat juxtaglomerular cells.

  1997cites this paper
• Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies.

  1997cites this paper
• Selective and nonselective dopamine receptor agonists: an innovative approach to cardiovascular disease treatment.

  1996cites this paper
• In vitro effects of the selective dopamine 1-agonist fenoldopam on the coagulation system in native whole blood: comparison to dopamine and nitroprusside.

  1995cites this paper
• Effects of fenoldopam on intracranial pressure and hemodynamic variables at normal and elevated intracranial pressure in anesthetized pigs.

  1994cites this paper
• Fenoldopam Mesylate Versus Sodium Nitroprusside in the Acute Management of Severe Systemic Hypertension

  1993cites this paper
• [Dopexamine: a new dopaminergic agonist].

  1993cites this paper
• Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.

  1993cites this paper
• Hemodynamic profile of intravenous fenoldopam in patients with hypertensive crisis

  1993cites this paper
• Dopamine and the kidney: ten years on.

  1993cites this paper
• Inotropic support of the critically ill patient. A review of the agents.

  1993cites this paper
• Fenoldopam infusion for the treatment of postoperative hypertension.

  1993cites this paper
• La dopexamine : un nouvel agoniste dopaminergique

  1993cites this paper
• Intravenous fenoldopam infusion in severe heart failure

  1993cites this paper
• Inotropic Support of the Critically Ill Patient

  1993cites this paper
• Selective dopamine-1 receptor agonist augments regional myocardial blood flow: comparison of fenoldopam and dopamine.

  1992cites this paper
• Cardiovascular Function During Induced Hypotension by Fenoldopam or Sodium Nitroprusside in Anesthetized Dogs

  1992cites this paper
• Synthesis and renal vasodilator activity of substituted [4-alkyl(aryl)quinazolin-2-one-1-yl]alkanoic acids

  1992cites this paper
• Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipients.

  1992cites this paper
• Comparative effects of fenoldopam mesylate and nitroprusside on left ventricular performance in severe systemic hypertension.

  1992cites this paper
• Effect of fenoldopam prodrug, SK&F R‐105058, on renal function in rats

  1992cites this paper
• 5-Hydroxytryptamine receptor activity of the dopamine receptor agonist fenoldopam in canine tracheal smooth muscle.

  1992cites this paper
• Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam.

  1992cites this paper
• ANESTHETIC MANAGEMENT OF THORACIC AORTIC SURGERY

  1992cites this paper
• Effect of L-dopa in Young Patients with Hypertension

  1991cites this paper
• Clinical pharmacology of ibopamine.

  1991cites this paper
• Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.

  1991cites this paper
• Dose‐response analysis of the effects of fenoldopam, dopamine‐1 receptor agonist, on renal function

  1991cites this paper
• Peripheral Dopamine Receptors in Cardiovascular Therapy The Legacy of Leon Goldberg (1927‐1989)

  1991cites this paper
• Drug receptors and control of the cardiovascular system: recent advances.

  1991cites this paper
• Dopamine agonists, a new perspective in cardiovascular therapy?

  1991cites this paper